Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer
Clinical trial NCT00280150 · COMPLETED
Trial details
- NCT number
- NCT00280150
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-01-01
- Primary completion
- 2012-01-01
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.